These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 15119695)

  • 1. C-reactive protein plasma levels but not factor VII activity predict clinical outcome in patients undergoing elective coronary intervention.
    Grander W; Dichtl W; Prokop W; Roithinger FX; Moes N; Friedrich G; Weidinger F; Pachinger O
    Clin Cardiol; 2004 Apr; 27(4):211-6. PubMed ID: 15119695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum C-reactive protein response to percutaneous coronary intervention in patients with unstable or stable angina pectoris is associated with the risk of clinical restenosis.
    Saleh N; Tornvall P
    Atherosclerosis; 2007 Dec; 195(2):374-8. PubMed ID: 17126343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic impact of preprocedural C reactive protein levels on 6-month angiographic and 1-year clinical outcomes after drug-eluting stent implantation.
    Park DW; Lee CW; Yun SC; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
    Heart; 2007 Sep; 93(9):1087-92. PubMed ID: 17309906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A persistent increase in C-reactive protein is a risk factor for restenosis in patients with stable angina who are not receiving statins.
    Hoshida S; Nishino M; Takeda T; Tanouchi J; Yamada Y; Hori M
    Atherosclerosis; 2004 Apr; 173(2):285-90. PubMed ID: 15064103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Greater pathogen burden but not elevated C-reactive protein increases the risk of clinical restenosis after percutaneous coronary intervention.
    Horne BD; Muhlestein JB; Strobel GG; Carlquist JF; Bair TL; Anderson JL;
    Am Heart J; 2002 Sep; 144(3):491-500. PubMed ID: 12228787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of interleukin-1 receptor antagonist in patients undergoing percutaneous coronary intervention.
    Patti G; Di Sciascio G; D'Ambrosio A; Dicuonzo G; Abbate A; Dobrina A
    Am J Cardiol; 2002 Feb; 89(4):372-6. PubMed ID: 11835913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic values of C-reactive protein levels on clinical outcome after implantation of sirolimus-eluting stents in patients on hemodialysis.
    Ishii H; Toriyama T; Aoyama T; Takahashi H; Amano T; Hayashi M; Tanaka M; Kawamura Y; Yasuda Y; Yuzawa Y; Maruyama S; Matsuo S; Matsubara T; Murohara T
    Circ Cardiovasc Interv; 2009 Dec; 2(6):513-8. PubMed ID: 20031768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum resistin levels and cardiovascular events in patients undergoing percutaneous coronary intervention.
    Momiyama Y; Ohmori R; Uto-Kondo H; Tanaka N; Kato R; Taniguchi H; Arakawa K; Nakamura H; Ohsuzu F
    J Atheroscler Thromb; 2011; 18(2):108-14. PubMed ID: 21071880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined periprocedural evaluation of CRP and TNF-alpha enhances the prediction of clinical restenosis and major adverse cardiac events in patients undergoing percutaneous coronary interventions.
    Kubica J; Kozinski M; Krzewina-Kowalska A; Zbikowska-Gotz M; Dymek G; Sukiennik A; Piasecki R; Bogdan M; Grzesk G; Chojnicki M; Dziedziczko A; Sypniewska G
    Int J Mol Med; 2005 Jul; 16(1):173-80. PubMed ID: 15942695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory response after intervention assessed by serial C-reactive protein measurements correlates with restenosis in patients treated with coronary stenting.
    Dibra A; Mehilli J; Braun S; Hadamitzky M; Baum H; Dirschinger J; Schühlen H; Schömig A; Kastrati A
    Am Heart J; 2005 Aug; 150(2):344-50. PubMed ID: 16086941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levels of plasma Quaking and cyclooxygenase-2 predict in-stent restenosis in patients with coronary artery disease after percutaneous coronary intervention.
    Wang P; Kuang Y; Liu Y; Zhang Y; Gao H; Ma Q
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Jun; 47(6):739-747. PubMed ID: 35837773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-procedural plasma levels of C-reactive protein and interleukin-6 do not predict late coronary angiographic restenosis after elective stenting.
    Segev A; Kassam S; Buller CE; Lau HK; Sparkes JD; Connelly PW; Seidelin PH; Natarajan MK; Cohen EA; Strauss BH
    Eur Heart J; 2004 Jun; 25(12):1029-35. PubMed ID: 15191773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preprocedural serum levels of acute-phase reactants and prognosis after percutaneous coronary intervention.
    Rahel BM; Visseren FL; Suttorp MJ; Plokker TH; Kelder JC; de Jongh BM; Bouter KP; Diepersloot RJ
    Cardiovasc Res; 2003 Oct; 60(1):136-40. PubMed ID: 14522415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of C-reactive protein to adverse cardiovascular events in patients treated by percutaneous coronary intervention for stable angina pectoris.
    Veselka J; Procházková S; Duchonová R; Homolová I; Tesar D
    Int Heart J; 2005 Mar; 46(2):195-204. PubMed ID: 15876803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An elevated value of C-reactive protein is the only predictive factor of restenosis after percutaneous coronary intervention.
    Jeong WK; Jeong MH; Kim KH; Lee SR; Park OY; Yum JH; Kim JH; Kim W; Rhew JY; Ahn YK; Cho JG; Ahn BH; Suh SP; Park JC; Kim SH; Kang JC
    Korean J Intern Med; 2003 Sep; 18(3):154-60. PubMed ID: 14619384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased C-reactive protein level after coronary stent implantation in patients with stable coronary artery disease.
    Almagor M; Keren A; Banai S
    Am Heart J; 2003 Feb; 145(2):248-53. PubMed ID: 12595841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic value of IL-8 for cardiac events and restenosis in patients with coronary heart diseases after percutaneous coronary intervention.
    Qi X; Li S; Li J
    Jpn Heart J; 2003 Sep; 44(5):623-32. PubMed ID: 14587644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic role of multiple biomarkers in stable patients undergoing fractional flow reserve-guided coronary angioplasty.
    Fracassi F; Niccoli G; Scalone G; Di Gioia G; Conte M; Bartunek J; Sgueglia GA; De Bruyne B; Montone RA; Wijns W; Crea F; Barbato E
    J Cardiovasc Med (Hagerstown); 2016 Sep; 17(9):687-93. PubMed ID: 26627500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical impact of high-sensitivity C-reactive protein during follow-up on long-term adverse clinical outcomes in patients with coronary artery disease treated with percutaneous coronary intervention.
    Shitara J; Ogita M; Wada H; Tsuboi S; Endo H; Doi S; Konishi H; Naito R; Dohi T; Kasai T; Okazaki S; Isoda K; Suwa S; Miyauchi K; Daida H
    J Cardiol; 2019 Jan; 73(1):45-50. PubMed ID: 30001869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous coronary intervention triggers a systemic inflammatory response in patients treated for in-stent restenosis -- comparison with stable and unstable angina.
    Kozinski M; Krzewina-Kowalska A; Kubica J; Zbikowska-Gotz M; Dymek G; Piasecki R; Sukiennik A; Grzesk G; Bogdan M; Chojnicki M; Dziedziczko A; Sypniewska G
    Inflamm Res; 2005 May; 54(5):187-93. PubMed ID: 15953990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.